Five Prime Therapeutics logo

Five Prime Therapeutics

Five Prime Therapeutics is a biotechnology company focused on the discovery and development of protein therapeutics, it was acquired by Amgen in 2021.

3

Funding Rounds

$55.0m

Money raised

Overview

Five Prime Therapeutics is a biotechnology company focused on the discovery and development of protein therapeutics, it was acquired by Amgen in 2021.

Funding

Funding series

Funding Series Analysis

The company Five Prime Therapeutics has raised a total of $55m in funding over 3 rounds.

Key Insights:

  • Five Prime Therapeutics funding round, April 2012: $10m
  • Five Prime Therapeutics funding round, February 2005: $45m
Five Prime Therapeutics logo
Five Prime Therapeutics funding round, April 2012 $10m
Five Prime Therapeutics logo
Five Prime Therapeutics funding round, February 2005 $45m

Industries

Five Prime Therapeutics is active in the following industries:
  • Healthcare
  • Biopharmaceutical
  • Diagnosis
  • Pharmaceutical industry
  • Consumer biotechnology
  • Technology
  • Biology
  • Biotechnology